The growing normalization of cosmetic procedures is reshaping how many women approach appearance, ageing and professional identity, according to consumers and experts who describe a shift from treatments once associated with wealth and exclusivity to services increasingly marketed as routine aspects of personal care.

The expansion of aesthetic treatments beyond specialist cosmetic clinics into settings such as dental practices and shopping centres has contributed to their wider acceptance, reducing barriers to access while altering public perceptions of who uses such services and why.

Dr. Jasmine Fardouly, a senior lecturer in psychology at the University of Sydney, said the broader availability of cosmetic interventions has changed the way they are viewed by consumers. Procedures that were once considered luxury purchases have increasingly been presented alongside everyday beauty and grooming services.

According to Fardouly, the growing accessibility of treatments has weakened their association with exclusivity while positioning them as ordinary consumer decisions comparable to other appearance-related expenditures.

At the same time, she noted that cultural attitudes toward appearance remain complex. While aesthetic procedures are increasingly accepted, debates continue over the amount of time, money and attention women devote to maintaining their appearance.“I think there is also a pushback against the amount of money and time women place on their appearance,” Fardouly said.

“It can create a class divide in that only women who can afford these procedures can meet these ideals.”Her comments reflect broader questions about affordability and access. As cosmetic procedures become more common, the financial commitment required to maintain regular treatments remains significant for many consumers.

For some women, aesthetic interventions are viewed as part of a progression of personal care practices that begin early in adulthood and evolve over time. Munson, a relief teacher, described cosmetic treatments as an extension of routines that initially included services such as eyebrow waxing and facial treatments.

She said the cost of maintaining cosmetic procedures is substantial relative to her income. According to Munson, a single day’s wage as a relief teacher is sufficient to cover only one Botox treatment.“It is a big number for us, but my partner looks after the household,” she said.

Munson explained that she sees cosmetic procedures as part of a broader pattern of appearance-related maintenance that has become normalized across different stages of life.“I remember as a teenager going to get my eyebrows waxed. As you get older, you hit 20, you start doing some more intensive facials. This is just what you do,” she said.

Her experience illustrates how aesthetic procedures are increasingly integrated into established beauty routines rather than being regarded as exceptional or uncommon choices.The trend is also evident among professional women who view cosmetic treatments as serving practical as well as personal purposes. Tania Zanetich, a 45-year-old finance professional, said she has observed a growing number of friends and colleagues using aesthetic interventions, regardless of age, cultural background or income level.

Speaking about her social circle, Zanetich said cosmetic treatments now appear across a broad spectrum of consumers, although approaches vary considerably.“I’ve got friendships with women from all cultures, all ages and budgets and girlfriends with big lips, who look like they’ve had work done and want the perception of wealth, and some of us that are very subtle,” she said.

Zanetich said she began receiving Botox and filler treatments in her mid-thirties. Her initial motivation combined medical and cosmetic considerations, including headaches and concerns about developing facial lines.“It was positioned to me as preventative of ageing, while also helping me clinically and I enjoyed the benefits,” she said.Over time, she said, the role of these treatments expanded beyond appearance alone. In her view, cosmetic procedures can influence how individuals perceive themselves and how they believe they are perceived by others in professional environments.

Zanetich described confidence and presentation as important factors in corporate settings, where personal appearance can become intertwined with broader perceptions of professionalism.“Joking the other day with my accountant, I said, surely Botox should be a tax deduction, because at work, I look like I can’t frown,” she said.She added that maintaining a composed appearance can influence workplace interactions.“If someone says something in a meeting, I’m looking poised,” she said.

“I think in a corporate workplace, if you are a mother of two small children, when you present yourself with a certain decorum, that image translates to a level of competency that might extend to my ability to do my job well.”Such observations highlight the evolving role of cosmetic procedures in professional contexts. While aesthetic treatments are often discussed in relation to beauty standards, some consumers increasingly describe them as tools that support confidence, self-presentation and workplace identity.

The debate surrounding cosmetic interventions remains highly polarized. Public discussions frequently frame women as either embracing or rejecting aesthetic treatments, creating contrasting narratives around authenticity, ageing and self-expression.However, the experiences described by consumers suggest a more nuanced reality.

Rather than viewing procedures solely through the lens of vanity or resistance to ageing, many women describe making decisions within a broader set of social, economic and professional considerations.The mainstream adoption of cosmetic procedures also reflects longstanding pressures associated with appearance.

As treatments become more accessible, they are increasingly framed as matters of individual choice, even as broader societal expectations continue to influence decisions about beauty and ageing.For some women, the emotional benefits associated with cosmetic procedures can outweigh concerns about cost.

Zanetich said she has encountered women who place significant value on the confidence they derive from treatments, viewing them as an important component of their wellbeing and daily functioning.“Women around me say, ‘if I had to choose between my Botox or buying groceries, I would cut back on groceries’ because of how it makes them feel, and how they are able to tackle the day to day,” she said.

Despite differing opinions on cosmetic interventions, Zanetich argued that women face sufficient scrutiny from society without additional judgment from one another.“I don’t judge anybody,” she said. “I think society judges women enough for us to judge each other.”

A growing number of women, healthcare professionals and advocates are calling for greater awareness and research into Premenstrual Dysphoric Disorder (PMDD), a severe hormone-related condition that can have profound effects on mental health, family relationships and quality of life but remains widely underdiagnosed and poorly understood.

Current research indicates that PMDD affects up to one in 20 women of reproductive age. Despite its prevalence, only about 1.6% of affected individuals receive a formal diagnosis. The consequences can be severe. Research cited in the source material indicates that approximately one-third of those diagnosed with PMDD have attempted suicide, underscoring the condition’s significant mental health burden.

PMDD is characterized by severe emotional, psychological and physical symptoms that occur during the luteal phase of the menstrual cycle, typically in the days before menstruation. However, many patients report years of confusion, misdiagnosis and ineffective treatment before receiving appropriate care.

Limited awareness within the medical community has contributed to delayed diagnosis and treatment, according to patients and healthcare professionals interviewed about their experiences. The condition remains unfamiliar to many clinicians despite its potentially debilitating effects.

The lack of understanding extends beyond clinical diagnosis. Relatively little is known about how PMDD affects family dynamics, particularly relationships between mothers and their children. In response to these gaps, the United Kingdom has recently seen the establishment of its first charity dedicated exclusively to supporting individuals with PMDD and their families.

For families living with the condition, the impact can extend far beyond the individual experiencing symptoms.Daly, now 37, recalls growing up in a household affected by her mother’s undiagnosed PMDD. She remembers frequent and intense arguments between her parents before treatment became available.

“I’d feel sad because she’d be crying – I hated seeing her so upset,” Daly said.Reflecting on her childhood, Daly described periods when her mother’s behavior was difficult to understand.“Mum was hard work at points. I’d sometimes overhear her shouting at Dad and think, this is unfair,” she said.

For many women diagnosed later in life, understanding the source of recurring emotional distress can bring both relief and regret. Barker, another woman living with PMDD, described years of struggling with symptoms that affected her relationships and self-perception.“I’d say nasty things, and felt unable to stop, then afterwards think: that was awful,” Barker said.

She described a recurring cycle in which episodes of anger and emotional instability were followed by periods of remorse, depression and repeated apologies.“Then the tears and depression came, I’d spend a week apologising – then it’d start all over,” she said.

Barker’s experience also highlights the connection between PMDD and serious mental health challenges. Visible reminders of that period remain part of her daily life.

Tattoos now cover self-harm scars from some of the most difficult years of her illness.A significant turning point came when consultant gynecologist Professor John Studd introduced her to treatment involving oestrogen implants. According to Barker, the results were immediate and transformative.“It was the only thing that worked – my symptoms disappeared,” she said.

However, access to treatment proved challenging. Barker said the National Health Service declined to fund the therapy because PMDD was classified as a syndrome rather than a disease, affecting eligibility for coverage.Determined to continue treatment, she contacted physicians, elected officials and healthcare providers while relocating from Hampshire to Edinburgh.

The process ultimately required substantial personal financial investment.“I ended up paying £600 every six months to travel to London and get a new implant fitted at my own expense,” Barker said.Despite the costs, she described the treatment as indispensable.“Life on the oestrogen implant was heaven,” she said.

At one point, Barker said her daughter loaned her £1,000 to help finance continued treatment after her own financial resources became strained.Even after finding an effective medical intervention, Barker said she remained concerned about the effect PMDD had already had on her children.

“I worried I’d ruined my relationship with my kids,” she said.She believes receiving treatment before her children reached adolescence helped prevent further difficulties, but she remains conscious of the years lost to managing symptoms.“I was lucky to get treatment before their teens.

But as younger kids, they grew up around me, not with me,” she said. “I was on the outside looking in, trying to manage and hide my symptoms. They bore the brunt.”According to Barker, successful treatment allowed her to reconnect emotionally with her family in ways that had previously been difficult.She said it enabled her “to feel the love and joy from spending time with the kids which PMDD had stolen.”The lack of awareness surrounding PMDD is not limited to patients.

Healthcare professionals themselves can experience the condition without recognizing it.Dr. Milli Raizada, a general practitioner and specialist in women’s health, said she had never heard of PMDD before being diagnosed with it six years ago, despite years of medical training and clinical experience.Now 40, Raizada said the diagnosis exposed significant shortcomings in professional education regarding women’s health conditions.

She described feeling disappointed that a condition affecting so many women remained largely absent from medical training.“Too many doctors, myself included, don’t have the knowledge to help women who suffer in silence,” she said.Raizada argues that improvements in medical education and research are essential if diagnosis and treatment rates are to improve.“Better training. More research.

Stop sidelining women’s health,” she said.Her own symptoms emerged after discontinuing oral contraceptive medication. According to Raizada, changes became apparent during the luteal phase of her menstrual cycle, when emotional and psychological symptoms intensified.“In the luteal phase, I’d be arguing lots with him and he said, ‘This isn’t normal’,” she said, referring to observations made by her husband.

Raizada described a sharp contrast between her usual personality and the symptoms she experienced during affected periods.“I’m usually resilient and a multitasker but I suddenly had impostor syndrome, felt overwhelmed and worthless, and was hypersensitive and apathetic for two weeks of the month,” she said.

The turning point came after an unusually intense reaction to a routine family interaction.“After flying off the handle at my mother-in-law over a throwaway comment, I knew it was time to act,” Raizada said.For advocates and patients, such experiences illustrate the urgent need for greater recognition of PMDD within healthcare systems.

Despite affecting millions of women globally, the condition continues to be characterized by delayed diagnoses, inconsistent treatment access and limited research, leaving many patients to navigate years of symptoms before obtaining effective care.

The condition will now be known as Polyendocrine Metabolic Ovarian Syndrome, or PMOS, according to findings published in The Lancet and presented Tuesday at the European Congress of Endocrinology in Prague.Researchers said the previous name, commonly shortened to PCOS, frequently misled both patients and clinicians by emphasizing ovarian cysts, which are not present in every case and are not the defining feature of the disorder.

Dr. Terhi Piltonen of the University of Oulu, lead author of the Lancet paper and a related research letter published in JAMA Internal Medicine, said the terminology had contributed to delayed diagnoses and fragmented medical care.

Researchers said the new name was intended to better reflect the disorder’s broad hormonal, reproductive and metabolic effects, including infertility, irregular menstruation, insulin resistance, obesity, cardiovascular complications, anxiety and depression.Women with the condition often exhibit elevated levels of immature ovarian follicles rather than actual cysts, researchers noted.

The renaming initiative was coordinated by several international research groups and the Androgen Excess and PCOS Society following a multi-year consultation process involving more than 14,000 survey responses from patients and healthcare professionals, two international workshops and contributions from 56 medical, academic and patient advocacy organizations.

Medical experts said the terminology shift could help standardize care and improve awareness among clinicians, particularly because many patients remain undiagnosed or receive treatment focused narrowly on reproductive symptoms instead of broader metabolic risks.

Although PMOS remains incurable, symptoms can be managed through medication, dietary changes and exercise, according to guidance from the Endocrine Society.

Researchers said implementation of the new terminology would begin immediately, with plans over the next three years to integrate PMOS into clinical guidelines, medical education, health systems and international disease classification standards.

Mental health specialists are calling for expanded psychiatric support within maternity services, warning that perinatal mental illness remains one of the most widespread yet under-recognized complications associated with pregnancy and childbirth.

The concerns come amid growing attention to gaps in screening, specialist access and treatment pathways for women experiencing psychiatric symptoms during pregnancy and the postnatal period.

Experts in the field say many women continue to face delayed diagnosis and inconsistent care despite national guidelines recommending routine psychosocial screening during pregnancy.Edna Lekgabe, a perinatal psychiatrist and co-founder of WARM Health Collective⁠, said the scale of the issue remains poorly understood relative to other pregnancy-related complications.

“Mental illness is the number one complication of pregnancy and the postnatal period,” Lekgabe wrote in an analysis examining failures within current maternity mental healthcare systems.Perinatal mental illness refers to psychiatric conditions occurring during pregnancy or within the first year following childbirth. According to specialists and public health agencies, up to one in five women experience a diagnosable mental health condition during that period.

Conditions can include depression, anxiety disorders, post-traumatic stress disorder related to traumatic births, obsessive-compulsive symptoms involving intrusive fears about infant harm, and, in rare cases, postpartum psychosis.Medical experts classify postpartum psychosis as a psychiatric emergency because of the heightened risk of self-harm, suicide or harm to the infant if untreated.

Lekgabe described a recurring clinical pattern in which women initially report symptoms during routine antenatal care but are reassured that emotional distress, insomnia or anxiety are normal features of pregnancy.

According to her account, many patients eventually reach specialist psychiatric care only after symptoms have significantly worsened.One illustrative example described a pregnant woman experiencing severe insomnia, hopelessness and suicidal thinking during the third trimester after earlier concerns were dismissed as routine pregnancy-related stress. The psychiatrist noted the case was fictionalized but based on recurring patterns observed across hundreds of patients.

The issue has gained increasing attention internationally as healthcare systems attempt to integrate mental health more fully into maternal care frameworks. Public health researchers have repeatedly linked untreated perinatal psychiatric illness to poorer outcomes for both mothers and infants, including impaired maternal functioning, disrupted bonding and elevated long-term developmental risks for children.

Despite those risks, specialists say mental healthcare remains inconsistently integrated into maternity services.In Australia, national guidelines recommend routine psychosocial screening during pregnancy and after childbirth, with many providers using the Edinburgh Postnatal Depression Scale, a standardized questionnaire designed to identify women at risk of depression and anxiety.

Lekgabe argued, however, that screening tools alone are insufficient without accessible treatment systems behind them.

“A screening tool is only as good as the pathway behind it,” she wrote.Mental health advocates and clinicians have raised concerns that women identified as high-risk frequently encounter lengthy delays for psychiatric assessment or psychological treatment. In Australia’s public healthcare system, wait times for mental health services can extend for months, particularly outside major metropolitan areas.

The psychiatrist pointed to disparities between urban and regional care availability, noting that specialist mother-baby psychiatric units and dedicated perinatal mental health services remain concentrated in larger cities. Women dependent on public healthcare or unable to afford private treatment often face more limited access.

Organizations including PANDA (Perinatal Anxiety & Depression Australia)⁠ and Centre of Perinatal Excellence (COPE)⁠ have sought to increase public awareness and improve access to support services across Australia.

Lekgabe also identified cultural expectations surrounding motherhood as a barrier to early intervention. According to her analysis, social narratives that idealize pregnancy and early parenthood can lead women to interpret severe psychological distress as personal inadequacy rather than a treatable medical condition.

The psychiatrist referenced the growing use of the term “matrescence,” which describes the emotional and identity transition associated with becoming a mother. While acknowledging the concept’s value in normalizing emotional adjustment, Lekgabe warned against conflating ordinary stress or disorientation with clinically significant psychiatric illness.

“There is a vast difference between the disorientation of new parenthood and a major depressive episode,” she wrote.Specialists in maternal mental health have increasingly emphasized that early symptoms are often minimized both by patients themselves and by healthcare systems focused primarily on physical outcomes such as blood pressure, fetal development and obstetric complications.

Lekgabe said many women internalize the belief that struggling emotionally reflects failure as a parent rather than evidence of illness requiring treatment.“I thought I was just a bad mother,” she said patients frequently tell her.The psychiatrist argued that statement reflects systemic diagnostic failure, particularly when women interact repeatedly with healthcare providers without receiving meaningful psychiatric evaluation or referral.

Mental health professionals have advocated for a more integrated care model in which psychiatric services are embedded directly within maternity clinics and obstetric care settings. Under such systems, psychiatrists, psychologists and mental health nurses would work alongside obstetricians and midwives rather than operating through separate referral systems.

Lekgabe identified three priorities for reform: integrating mental healthcare into maternity services, expanding the number of trained perinatal psychiatrists and improving public understanding of perinatal psychiatric illness.Australia currently has relatively few psychiatrists specializing in perinatal and reproductive mental health compared with overall demand, according to clinicians in the field.

Training opportunities within the subspecialty also remain limited.The psychiatrist stressed that perinatal mental illness is highly treatable when recognized early and managed appropriately. Treatment options can include psychotherapy, medication considered safe during pregnancy, supported birth planning and coordinated postpartum care.

The fictionalized patient example described in Lekgabe’s analysis ultimately improved after receiving psychiatric medication, psychological treatment and coordinated maternity support tailored to her mental health needs.However, the psychiatrist argued that many women never receive that level of coordinated intervention.

“Not every woman who walks the path Mia walked finds that team,” Lekgabe wrote.

Mental health organizations globally have increasingly highlighted maternal suicide and severe psychiatric illness as major public health concerns linked to inadequate perinatal care systems. Several countries, including the United Kingdom and Australia, have expanded investment in specialized maternal mental health programs over the past decade, though advocates argue access remains uneven.

Lekgabe said greater public literacy around perinatal psychiatric illness could help reduce stigma and encourage earlier intervention among expectant parents and their families.

“We need expectant parents and their families to understand that perinatal mental illness is common, treatable and not a reflection of character,” she wrote.

At Jemo Health Centre on the outskirts of Addis Ababa, health worker Tewodros Tibebu says social stigma and limited awareness continue to delay access to comprehensive abortion care, despite Ethiopia legalizing broad abortion services more than two decades ago.

Tibebu, who has worked in comprehensive abortion care for four years, is among only three trained providers currently delivering the service at the facility. According to his account, many patients arrive after significant delays, often seeking help only after complications emerge from procedures carried out elsewhere.

“The biggest challenge is stigma,” Tibebu said in a feature published by the World Health Organization on May 5. “Many women are afraid someone will recognize them when they come here. Others do not even know the service exists.”Comprehensive abortion care has reportedly been available at Jemo Health Centre for nearly a decade.

However, Tibebu said access barriers remain widespread, particularly for women seeking confidential and medically supervised treatment.According to his account, many patients first visit private clinics where procedures may be carried out by practitioners lacking formal training in abortion care. By the time some women reach public facilities such as Jemo, they are already suffering from infections or sepsis that could have been prevented through earlier medical intervention.

Ethiopia expanded legal access to abortion in 2005 under revised provisions that allowed the procedure under broader circumstances than previously permitted. Despite the legal framework, health care providers and reproductive health organizations have continued to report uneven access across regions, driven by social stigma, provider shortages and gaps in public awareness.

Tibebu said the stigma surrounding abortion services affects providers as well as patients. “Some coworkers oppose the comprehensive abortion care department,” he said. “Some people in my community do not know what I do.”The social pressures attached to abortion care are a recurring issue in reproductive health systems globally, particularly in countries where legal reforms have outpaced shifts in public attitudes or health infrastructure.

Health workers often face professional isolation, ethical scrutiny and personal criticism while providing services that remain politically and culturally contested.Tibebu said professional training helped him better understand both the clinical and ethical dimensions of abortion care. “Before, it was difficult,” he said.

“After I received specific training, I understood the work differently and could provide the care women need.”The experiences described by Tibebu formed part of a broader announcement by the Human Reproduction Programme, known as HRP, regarding a new international training initiative on comprehensive abortion care.

The programme, launched through the WHO Academy platform, combines four separate learning modules focused on medical abortion, surgical abortion, post-abortion care and human rights integration in comprehensive abortion care. According to HRP, the courses are designed to provide modular and interactive learning environments that simulate real clinical decision-making scenarios encountered by frontline health workers.

WHO said the training initiative is intended to strengthen evidence-based care and improve consistency in abortion services across different health systems. The programme also places emphasis on privacy, non-discrimination and accountability within clinical practice.

The human rights integration component links medical treatment with broader principles related to patient dignity and access to care, according to WHO. Together, the courses are intended to establish a standardized framework for providers working in comprehensive abortion care settings.The launch reflects continuing international efforts by global health organizations to reduce preventable maternal complications associated with unsafe abortion procedures.

WHO has repeatedly stated in policy guidance that access to trained providers, accurate information and safe clinical environments are central to reducing maternal morbidity and mortality.At facilities such as Jemo Health Centre, providers say the gap between legal availability and practical access remains significant.

Tibebu noted that many patients learn about the service only through informal networks and word-of-mouth referrals rather than official health campaigns or referrals from primary care systems.That reliance on informal communication channels, he said, contributes to delays that can worsen medical outcomes.

The WHO feature also highlighted the operational pressures facing providers in facilities with limited staffing. With only three trained workers handling abortion care services at Jemo, workloads remain concentrated among a small number of clinicians.

Training programmes such as the one launched by HRP are intended in part to address those shortages by expanding provider knowledge and strengthening clinical capacity. WHO said the interactive nature of the courses allows health workers to engage with practical decision points similar to those encountered during patient care.

The organization has increasingly used digital and modular learning systems to expand access to specialized medical training, particularly in lower-resource health settings where formal clinical education opportunities may be limited.Tibebu said the training reinforced his understanding of abortion care not only as a technical medical service but also as direct patient support during periods of vulnerability and medical risk.

“People may not understand what we do,” he said. “But when you think about the woman in front of you, the decision is clear. You are helping someone.”WHO separately announced a webinar linked to the comprehensive abortion care learning programme scheduled for April 28, 2026.

The organization also published updated abortion-related fact sheets in December 2025 as part of its broader reproductive health guidance materials.The HRP programme operates jointly under the United Nations Development Programme, the United Nations Population Fund, the United Nations Children’s Fund, WHO and the World Bank, focusing on research, policy development and training in human reproduction and reproductive health services.

Prevailing cultural narratives surrounding ageing and relationships are increasingly being challenged by accounts from women in their 60s and beyond, alongside research suggesting that postmenopausal years can be associated with greater autonomy, emotional stability and life satisfaction.

Popular discourse has often portrayed later-life dating prospects for women as limited, with media depictions and advice literature historically reinforcing expectations of diminished opportunity. Some narratives suggest that older women must lower expectations in seeking partners, while fictional portrayals frequently depict isolation and decline. These assumptions, however, are not consistently reflected in personal accounts or emerging expert analysis.

One 67-year-old woman, reflecting on her experience, reported living in a stable relationship for eight years with a partner seven years younger than her. She described similar patterns among peers in their 60s, noting that many maintain active social and romantic lives that contradict stereotypes of disengagement. Such accounts highlight a divergence between cultural perceptions and lived experiences.

Public figures have also described shifts in perspective with age. Mariella Frostrup, speaking about her experience at 63, said she now feels “much more in control” of her decisions and less constrained by external judgment. Penny Smith, 67, similarly described reduced pressure to conform to social expectations, noting that clarity about personal preferences increases with age.

Academic and medical perspectives provide additional context. Christiane Northrup, author of The Wisdom of Menopause, characterises the postmenopausal phase as a “time of awakening,” in which women reclaim energy and creativity. Gail Sheehy, in her book New Passages, argues that this life stage can coincide with renewed purpose and productivity, describing it as one of the most fulfilling periods for many women.

Neuropsychiatric research has examined physiological and psychological factors associated with menopause. Louann Brizendine has attributed reported increases in emotional clarity and resilience to reduced hormonal fluctuations following menopause. According to her analysis, this shift can contribute to a more stable emotional baseline, which may influence decision-making and interpersonal relationships.

Social attitudes toward menopause have also evolved over time. Earlier generations often approached the subject with limited public discussion, sometimes framed in negative or stigmatized terms. While contemporary discourse has become more open, some narratives continue to emphasise decline rather than adaptation or opportunity.

At the same time, broader demographic and health trends indicate that women are living longer and maintaining higher levels of activity later in life. The implication, according to researchers and commentators cited in the source material, is that postmenopausal years represent a significant portion of the lifespan, during which individuals may pursue personal, social and professional interests with fewer constraints.

Personal testimonies suggest that this period is often associated with increased self-awareness and independence. Women interviewed in the source material described greater willingness to set boundaries, prioritise personal preferences and engage in social activities aligned with their interests. These accounts align with expert views that reduced caregiving responsibilities and accumulated life experience can contribute to a sense of autonomy.

The shift in perception also intersects with changing cultural norms around ageing, relationships and gender roles. While traditional frameworks often positioned youth as central to identity and desirability, current discussions increasingly recognise diverse experiences across the lifespan.

This includes acknowledgment of continued social engagement, romantic relationships and personal development in later years.Medical experts emphasise that outcomes in postmenopausal years are influenced by overall health. Individuals maintaining good health in midlife are more likely to experience extended longevity, with the potential for active lifestyles into their 80s and 90s.

This demographic reality reinforces the importance of understanding ageing not solely as decline but as a prolonged phase of life with distinct characteristics.The evolving narrative around menopause reflects both individual experiences and broader societal change.

While challenges associated with ageing remain, the accounts and expert analyses presented indicate a shift toward recognising later life as a period marked by agency, resilience and continued participation in social and personal domains.

For years, she wanted a child. After a decade of waiting, hope and uncertainty, pregnancy finally arrived carrying both joy and fear in equal measure. What followed, however, was not the soft, instinctive transition into motherhood that culture often promises, but a physically traumatic birth, emotional numbness and a long struggle to recognise herself in her new life.

During pregnancy, she found herself largely alone. Her husband, though supportive and loving, was frequently absent, consumed by the demands of a startup consultancy he had recently founded with two academic partners.

Medical appointments, including an amniocentesis prompted by concerns over possible chromosomal abnormalities, were often faced without him because he was abroad for work.

She attended prenatal classes, but support systems felt limited. Only one person in her close circle had children, and her relationship with her own mother, who lived in Italy, was strained. The isolation deepened her anxiety, particularly because childbirth itself frightened her.

When she raised those fears with her general practitioner, she recalls receiving a familiar reassurance that did little to ease them.“Don’t worry, birth isn’t an illness,” her male GP told her. “It’s all perfectly natural.”She felt the dismissal ignored her lived reality. She was asthmatic and suffering from undiagnosed endometriosis that caused severe pain every few weeks.

Pregnancy did not feel simple or natural. It felt uncertain and medically significant.Still, she felt deeply connected to the child growing inside her. She recognised her daughter through movement alone—the shape of limbs pressing against skin, strong kicks in response to passing sirens, a physical presence both strange and intimate.

She imagined a temperament already forming: long legs like her father, a temper like her own.She expected love to be immediate. After waiting so long, how could it not be?Her due date passed. Then another week.

Then another. At more than 44 weeks pregnant, she says she had to insist repeatedly before her GP agreed to induction. Only when hospital monitoring showed signs of fetal distress did medical staff finally intervene and break her waters.

Labour lasted 20 hours.

She describes induced labour not as a gradual progression but as a sudden collapse into nausea, pain and exhaustion. Hours passed with no progress. She was unable to receive an epidural at first because she was not dilating. The pain became all-consuming.

At one point, fearing the worst, she asked her husband to make a promise: if doctors had to choose between saving her life and their child’s, he should choose the baby.“I am not going to lose either of you,” he replied.

She remembers University College Hospital at the time as a place that inspired little confidence—a crumbling Victorian building with filthy bathrooms, blood on the floors and junior doctors exhausted by punishing shifts. Around her, the maternity ward echoed with the sounds of women in labour: groans, cries, gasps and fear.Eventually she received an epidural, but the baby remained stuck.

Just before midnight, an emergency forceps delivery and episiotomy were performed. Her husband later told her there were 13 people in the room.Then their daughter arrived.She weighed just under 4.5 kilograms—almost 10 pounds.

The mother had lost so much blood that the experience felt, in her words, like surviving a car crash. Her husband, standing in blood-soaked jeans, was overwhelmed with joy.“Isn’t she wonderful?” he said.She felt nothing.

She describes the absence of emotion not as rejection, but as total numbness, as though the epidural that had numbed her body had also severed access to feeling. She spent the night awake in the recovery ward waiting for the expected rush of maternal love that never came, listening to other women crying as anaesthesia wore off.

Instead, she felt transported back to boarding school dormitories, where she had learned early to suppress everything except anger.“Rage has served me quite often as a stimulant against exhaustion,” she writes. “Every woman who goes through childbirth has, I believe, been through the equivalent of war.

”She compares childbirth to trauma rather than celebration, arguing that many women leave the experience carrying symptoms closer to post-traumatic stress than to joy.

She believes poor maternity care intensified that reality.Her experience took place during years of severe strain on Britain’s National Health Service, when long-term underfunding and overstretched staff affected standards of care.

But she also sees a broader cultural issue: motherhood itself, she argues, is often insufficiently respected.At the time, general practice and obstetrics were still dominated by men.

She does not argue that male doctors cannot provide excellent care, but believes many failed to understand how dangerous childbirth could still be, or how often women’s pain was normalised rather than addressed.She was discharged the next day after a blood transfusion and severe physical trauma. She could barely walk.

Her husband worried about her physical recovery, but neither of them recognised the mental damage taking shape beneath it.When the baby began crying—night after night, almost without pause motherhood became a contest between exhaustion and fury.

“Once our baby began to cry relentlessly every night, all night, it felt like a battle between my rage and hers,” she recalls.Then one day, something changed.Her daughter, whose eyes had until then seemed distant and unfocused, suddenly looked directly at her. Then came a smile—clear, unmistakable and full.It was not simply recognition. It felt like acceptance.

“She seemed not only to recognise me, but to greet me with unconditional love and delight,” she writes.She understood intellectually that infant smiles are biological survival mechanisms, but the emotional impact was overwhelming.

The joy felt so sharp it was almost painful.“Oh!” she remembers saying. “It’s you. It’s you.”That first smile altered everything.The sleepless nights did not disappear. The crying continued. But something fundamental shifted in her understanding of motherhood, of love and even of her own mother.

Her relationship with her mother, long marked by pain and distance, softened. She began to understand her mother’s own unresolved grief and emotional absences not simply as cruelty, but as the result of childhood bereavement and wounds never healed.Motherhood brought not only responsibility, but perspective.

As a writer, she found that literature had offered little preparation for the reality of childbirth. Victorian novels she loved moved quickly past pregnancy and motherhood, treating them as narrative transitions rather than lived experiences.

Even contemporary women writers often avoided describing the devastation of birth itself.When she included the physical brutality of childbirth in her 1996 novel A Vicious Circle, critics attacked what one reviewer called “revolting details.”

Yet she says she had still softened the truth, giving her fictional heroine an instant maternal bond she herself had not felt.Years later, much changed. Hospitals improved. Her GP practice became staffed by younger, mostly women doctors. She had a second child, a son, whose birth was entirely different and with whom she bonded immediately.

Her daughter, Leon, grew into a novelist herself—healthy, loving and brilliant.Looking back, she says motherhood brought both unimaginable suffering and extraordinary love.

Public conversation often reduces it to either sentimental joy or unbearable hardship. The truth, she argues, is both.And if the early days felt like darkness, what remained was not the trauma alone, but the light that followed.

India’s largest drugmaker by market value said it would pay $14 per share for Organon, representing a premium of more than 24% to Organon’s April 24 closing price, as it accelerates its strategy to deepen exposure to higher-margin specialty therapies including dermatology, oncology and obesity treatments.

The acquisition also strengthens Sun Pharma’s presence in women’s health and gives it entry into biosimilars, while broadening its reach into markets such as China, Brazil and other emerging economies where its footprint has been comparatively limited.

Sun Pharma shares closed 7% higher on Monday, adding 271.36 billion rupees ($2.88 billion) in market value, after rising as much as 9% earlier in the session. Organon shares rose 16% in premarket U.S. trading to $14.06.The deal includes Organon’s net debt of about $8.6 billion as of Dec. 31, 2025.

Sun said it would finance the transaction through a combination of existing cash reserves and committed bank financing.As of the same date, Sun Pharma’s debt stood at roughly $198.4 million, while annual profit was about $1.16 billion, giving it relatively strong balance sheet flexibility compared with the scale of the acquisition.

Analysts said the transaction would materially increase Sun’s earnings capacity and strengthen its long-term strategic positioning.Nuvama Institutional Equities analyst Shrikant Akolkar said the acquisition would effectively double Sun’s revenue and EBITDA by adding approximately $6.2 billion in sales with EBITDA margins of around 30%.

He said the transaction could be 30% to 40% earnings-per-share accretive by fiscal year 2028.“Funding is coming from a strong balance sheet, and debt concerns should ease by the third year,” Akolkar said, adding that the deal positions Sun to become a more dominant global pharmaceutical player by the end of the decade.

Organon’s portfolio includes more than 70 women’s health and general medicine products sold across around 140 countries, offering Sun a steady cash-generating business alongside its specialty drug pipeline.

The acquisition comes as Indian drugmakers with significant U.S. exposure face pressure from shifting U.S. tariff policies and pricing challenges in the generics market, prompting companies to seek stronger margins through branded specialty medicines and broader geographic diversification.

While analysts view the deal as strongly positive for earnings, some noted it may not dramatically alter Sun’s competitive standing in the U.S. market because Organon’s American business remains relatively modest.

Still, the transaction represents a major strategic step for Sun Pharma as it seeks to reduce dependence on traditional generic drug sales and strengthen its position as a global branded and specialty pharmaceuticals player.

The initiative—part of a five-year, state-wide campaign—seeks to reach 25,500 young women across 11 universities in Uttarakhand with lifesaving education on early detection and risk reduction. The programme at Doon University will bring together medical experts, public health advocates, and students in an interactive, data-driven effort to change the trajectory of breast cancer outcomes in India.

Breast cancer remains one of the most prevalent cancers worldwide. In India, one in 28 women will develop the disease in their lifetime—rising to one in 22 in urban areas—and younger women are increasingly at risk.

Globally, experts warn that cultural myths, delayed detection, and inadequate screening continue to drive mortality rates.

The Doon University campaign seeks to close these gaps by challenging the misconception that breast cancer is solely an “older woman’s disease,” promoting self-examination and timely medical consultation, and equipping students with multilingual resources to extend awareness within their communities.

Event Highlights – 13 August 2025

The event on 13 August 2025 will open at 10:00 am with an address by the Vice Chancellor of Doon University, followed by an expert-led interactive session with Col. Mayank Chaubey and a team of doctors from 10:30 am to 12:30 pm.

The programme will also see the launch of the Doon University Youth Council for Breast Health, the distribution of self-examination guides in multiple languages, and a live question-and-answer session with healthcare professionals.

Concluding the morning, Dr. Rajesh Bhatt will present a psychological perspective on well-being from 12:30 pm to 1:30 pm.

This initiative builds on the momentum of the campaign’s first event, held on 18 July 2025 at Military Hospital Dehradun, where young women from the cantonment turned out in large numbers, surpassing expectations and engaging in lively, insightful discussions.

A Model for International Outreach

The BCYW Foundation’s Uttarakhand model is drawing attention from health advocacy groups worldwide as a promising and replicable blueprint for community-led, youth-focused cancer prevention. Its approach—embedding health literacy into academic environments—ensures that awareness begins early, within trusted spaces of learning. By combining medical expertise with student-driven outreach, the initiative not only addresses immediate knowledge gaps but also fosters a generation of informed health advocates.

This strategy aligns closely with the World Health Organization’s (WHO) global objectives for early detection, lifestyle-based prevention, and equitable access to information. International observers view it as a case study in how local initiatives, when well-structured, can resonate beyond national borders.

At a time when global cancer rates are climbing and younger demographics are increasingly affected, the upcoming Doon University event highlights the urgency of merging public health diplomacy with grassroots engagement. It transforms university campuses into hubs of wellness activism—places where education, prevention, and empowerment intersect to create lasting change, both locally and globally.